Study sees no tie between Merck's Gardasil and VTE risk; Judge again smacks down Zohydro restrictions;

@FiercePharma: Biogen prices new, long-acting hemophilia med with eye on patient-switching. Story via FiercePharmaMarketing | Follow @FiercePharma

@EricPFierce: Health Canada tells GSK to get its vaccine house in order as flu season approaches. More | Follow @EricPFierce

@CarlyHFierce: Report: Cancer immunotherapy market to hit $9B by 2022. Item | Follow @CarlyHFierce

> Facing restrictions on OTC sales of antibiotics, Vietnam's largest drugmaker,DHG Pharmaceutical, plans to expand exports into Myanmar. Story

> Lobbying pressure from drugmakers and biotechs may have forced a U.S. senator to drop a bill addressing patent trolls. Report

> A new study found no evidence of a link between Merck's ($MRK) HPV vaccine Gardasil and higher risk for venous thromboembolism (VTE) in the period following vaccination. More

> A federal judge has again stepped on efforts by Massachusetts Gov. Deval Patrick to restrict sales of the opioid drug Zohydro. Story

Medical Device News

@FierceMedDev: Proteome Sciences, U.K. academics spot 10 Alzheimer's predictive biomarkers in blood. FierceDiagnostics story | Follow @FierceMedDev

@StacyALawrence: Surgeons tout benefits of Google Glass in operating room. More | Follow @StacyALawrence

@VarunSaxena2: Check out our special report on the top 10 highest paid med tech CEOs. | Follow @VarunSaxena2

@MichaelGFierce: MIT, MicroCHIPS develop remote-controlled contraceptive with on-off delivery. FierceDrugDelivery story | Follow @MichaelGFierce

@EmilyWFierce: Volatile compounds in fruits influence our perception of taste and smell, could trick us into healthy eating. Wired story | Follow @EmilyWFierce

> India may alter medical device taxation that favors imports. Item

> Zimmer, Biomet hit regulatory speedbump in pending merger. Story

> NeuroMetrix gains on FDA clearance of over-the-counter wearable, chronic pain device. Article

Biotech News

@FierceBiotech: Trending on FierceDrugDelivery: @MIT, MicroCHIPS develop remote-controlled contraceptive with on-off delivery. Story | Follow @FierceBiotech

@JohnCFierce: After a taste of disaster, Reata plans a comeback for bardoxolone - in Ph2 for PAH now after CKD blowup. News | Follow @JohnCFierce

@DamianFierce: Bernstein's Porges: "Wouldn't hold our breath" for any meaningful AS revenue from CELG's apremilast. More | Follow @DamianFierce

@EmilyMFierce: Oops: Smallpox discovered sitting in Maryland storage room. Story via The Washington Post | Follow @EmilyMFierce

> Sanofi ups the legal ante to block Lilly's Lantus biosimilar. Report

> International brouhaha over AbbVie misstep highlights U.K.'s M&A rules. Item

> Antibody expert arGEN-X pulls off a $54.5M IPO. News

> NIH sickle cell partner AesRx moves up the food chain in Baxter buyout. More

> After a taste of disaster, Reata plans a comeback for bardoxolone. Story

Drug Delivery News

> Researchers develop new chemo that targets mitochondrial DNA. Report

> Sanofi Pasteur taps CureVac for its RNA vaccine tech. Story

> InSite plans 2015 FDA submission for inflammation eye drop with suspended delivery. News

> Vaginal ring achieves localized, sustained release of anti-HIV drugs. More

> MIT, MicroCHIPS develop remote-controlled contraceptive with on-off delivery. Article

Diagnostics News

> U.K. company readies jump into bustling prenatal Dx market. Article

> NIH gives Kansas City startup $3M to come up with a quicker sepsis Dx test. More

> UC San Diego biomarker discovery could boost brain cancer drug's success rate. Story

> With funding secured, Definiens CEO Heydler talks about hoped-for digital tissue Dx boom. Article

> Proteome Sciences, U.K. academics spot 10 Alzheimer's predictive biomarkers in blood. Report

Pharma Marketing News

> Which big brands will still be bringing in the big bucks in 2020? Report

> Merck reaches doctors in India with online teaching tool. More

> Biogen prices new, long-acting hemophilia med with eye on patient-switching. Article

> Report: Cancer immunotherapy market to hit $9B by 2022. Item

> Is a price war imminent when Sanofi's Lantus patent falls? Story

And Finally... The most recent revision of the Declaration of Helsinki weakens protections for trial participants in low- and middle-income countries, researchers say. Story

Suggested Articles

Former Indivior CEO Shaun Thaxter will face six months in federal prison for his role in misleading government officials on the dangers of Suboxone.

As of Friday after local time, 36 people have died in Korea after getting flu shots provided by at least seven companies, including Sanofi.

Two prominent pneumococcal vaccines from Merck and Pfizer are running low in Europe in a possible ill omen for the coming winter: report.